Copays must be collected, fees developed for extra oncology pay

Article Overview

This article covers CMS guidance affecting oncology practices participating in a chemotherapy-related demonstration payment. It focuses on patient cost-sharing, how practices were told to report the service on claims, whether charges need to be established for the related questions, and who may document the patient responses. It is relevant to oncology billers, compliance staff, and practice managers who need to understand the administrative requirements tied to the demonstration.